Cargando…

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Zaccardi, Francesco, Kloecker, David E., Buse, John B., Mathieu, Chantal, Khunti, Kamlesh, Davies, Melanie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	e-Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441544/ https://www.ncbi.nlm.nih.gov/pubmed/33334809 http://dx.doi.org/10.2337/dc20-2080

Ejemplares similares

Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
por: Crowley, Matthew J., et al.
Publicado: (2020)

Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis
por: Barker, Mary M, et al.
Publicado: (2022)

Temporal Trends in Lower-Limb Major and Minor Amputation and Revascularization Procedures in People With Diabetes in England During the COVID-19 Pandemic
por: Valabhji, Jonathan, et al.
Publicado: (2021)

Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
por: Vetrone, Lorenzo M., et al.
Publicado: (2018)

Cardiovascular events and mortality in people with and without type 2 diabetes: An observational study in a contemporary multi‐ethnic population
por: Coles, Briana, et al.
Publicado: (2020)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
por: Ahmad, Ehtasham, et al.
Publicado: (2020)

Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies
por: Zaccardi, Francesco, et al.
Publicado: (2016)

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
por: Rana, Jamal S., et al.
Publicado: (2021)

Sodium–Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions
por: Misaghian-Xanthos, Negin, et al.
Publicado: (2017)

Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients With Diabetes
por: Newman, Jonathan D., et al.
Publicado: (2019)

Using observational data to prioritise COVID-19 vaccination strategies: opportunity or necessity?
por: Zaccardi, F., et al.
Publicado: (2021)

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol
por: Hussein, Humaira, et al.
Publicado: (2018)

Cardiovascular Disease Protection in Long-Duration Type 1 Diabetes and Sex Differences
por: He, Zhiheng H., et al.
Publicado: (2015)

High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020)

Serum Potassium and Glucose Regulation in the ADDITION-Leicester Screening Study
por: Carter, Patrice, et al.
Publicado: (2015)

Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation
por: Razieh, Cameron, et al.
Publicado: (2021)

Prospective Associations of Waist-to-Height Ratio With Cardiovascular Events in Postmenopausal Women: Results From the Women’s Health Initiative
por: Lo, Kenneth, et al.
Publicado: (2019)

Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
por: Zaccardi, Francesco, et al.
Publicado: (2020)

Obesity and risk of COVID-19: analysis of UK biobank
por: Yates, Thomas, et al.
Publicado: (2020)

A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
por: Htike, Zin Z., et al.
Publicado: (2012)

Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes
por: Flory, James H., et al.
Publicado: (2020)

Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study
por: Yates, Thomas, et al.
Publicado: (2017)

Improving Diabetes Management and Cardiovascular Risk Factors Through Peer-Led Self-management Support Groups in Western Kenya
por: Park, Paul H., et al.
Publicado: (2015)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
por: Stapff, Manfred Paul
Publicado: (2018)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

Joint Prevalence of Diabetes, Impaired Glucose Regulation, Cardiovascular Disease Risk and Chronic Kidney Disease in South Asians and White Europeans
por: Khunti, Kamlesh, et al.
Publicado: (2013)

Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates
por: Zaccardi, Francesco, et al.
Publicado: (2018)

Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England
por: Ling, Suping, et al.
Publicado: (2023)

The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting
por: Willis, Andrew, et al.
Publicado: (2014)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
por: Kar, Debasish, et al.
Publicado: (2016)

Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease
por: Wilkinson, Thomas J., et al.
Publicado: (2022)

Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
por: Wang, Tiansheng, et al.
Publicado: (2019)

Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data
por: Coles, Briana, et al.
Publicado: (2020)

Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study
por: Rowlands, Alex V., et al.
Publicado: (2021)

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting
por: Wang, Tiansheng, et al.
Publicado: (2019)

Proteinuria and Risk of Lower-Extremity Amputation in Patients With Peripheral Artery Disease
por: Shin, Jung-Im, et al.
Publicado: (2019)

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
por: Khunti, Kamlesh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubfdbetjgj57o9j9ivf3l9ri6b